Products for Research Use Only
RegisterLogin

Fulzerasib

CAT: 0013-GTR19235814-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19235814-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fulzerasib is an oral, covalent KRAS G12C inhibitor with potent activity against mutant tumor cell lines, demonstrating IC50 values in the low nanomolar range. It is a key research tool for investigating KRAS-driven oncogenesis and is utilized in both in vitro and in vivo studies for non-small cell lung cancer (NSCLC) and other solid tumors harboring the G12C mutation.
CAS Number
2641747-54-6
Product Name Alternative
GFH 925, ,
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
98.04% (May vary between batches)
Solubility
DMSO:100 mg/mL (162.06 mM)
Smiles
O=C (C=C) N1CCN2C=3C=4C=C (Cl) C (=NC4N (C (=O) C3N (C (=O) C2C1) C) C=5C (=NC=CC5C) C (C) C) C=6C (F) =CC=CC6O
Molecular Formula
C32H30ClFN6O4
Molecular Weight
617.07
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
C01904-01Fulzerasib
A24228-5Fulzerasib (IBI351, GFH925) 5mg
A24228-1Fulzerasib (IBI351, GFH925) 1mg
A24228-50Fulzerasib (IBI351, GFH925) 50mg
A24228-10Fulzerasib (IBI351, GFH925) 10mg

Popular Products